The Israeli firm's Morpheus is used for cardio-sleep analysis.
Sleep diagnostic company WideMed Ltd. (TASE:WDMD) has reached a deal with Pfizer Inc. (NYSE:PFE; LSE:PFZ) sister company Pfizer Ltd. to use the for development of WideMed's Morpheus sleep analytics system. The agreement is for one year or until the completion of the work plan, whichever comes first.
Morpheus is a automated computer aided cardio-sleep information system, which has been approved by the US Food and Drug Administration (FDA). The system provides data on sleep stages, sleep apnea, and other disorders, in order to facilitate the application of appropriate treatments.
Published by Globes [online], Israel business news - www.globes-online.com - on December 23, 2007
© Copyright of Globes Publisher Itonut (1983) Ltd. 2007